Hovione
João Henriques has a diverse work experience spanning over several companies and roles. João started their career as a Trainee at Bayer Technology Services in 2006 and later worked as a Trainee at Merck KGaA. João then worked as a Research Assistant at Instituto Superior Técnico before joining Roche Pharmaceuticals as an External Consultant. João also worked as a Consultant at 4TUNE ENGINEERING LTD. In 2008, João joined Hovione and held various positions including PAT specialist, Manufacturing Systems Efficiency Expert, Particle Design and Pharmaceutical Development Engineer, and Drug Product Development Team Leader. Currently, they serve as the Director of Oral Drug Product Development at Hovione, where they lead the formulation group and focuses on research and development activities in multiple areas.
João Henriques obtained a Bachelor's degree in Biological Engineering from Instituto Superior Técnico in 2006. João later pursued a Master's degree in the same field at the same institution, with no specified end year.
This person is not in any offices
Hovione
2 followers
Hovione is an international company with over 60 years of experience in pharmaceutical development and manufacturing operations. As a Contract Development and Manufacturing Organization (CDMO) with a fully integrated offering of services for drug substances, drug product intermediates and drug products. The company has four FDA inspected sites in the USA, Portugal, Ireland and China and development laboratories in Lisbon, Portugal and New Jersey, USA. Hovione provides pharmaceutical customers services for the development and compliant manufacture of innovative drugs, including highly potent compounds, and customized product solutions across the entire drug life cycle. In the inhalation area, Hovione offers a complete range of services, from API, formulation development and devices. Hovione´s culture is based on innovation, quality and dependability. Hovione was the first Chemical/ Pharmaceutical Company to become a Certified B Corp, is a member of Rx-360, EFCG and participates actively in industry quality improvement initiatives to lead new global industry standards.